# EHR-Bench — microbiologyevents — qid=ehr_bench_decision_making_6711
**gold:** `['Respiratory Viral Culture', 'Respiratory Viral Antigen Screen']`

- Agentic F1 = **1.00** · final answer: `['Respiratory Viral Culture', 'Respiratory Viral Antigen Screen']`
- One-shot F1 = **0.00** · final answer: `['FUNGAL CULTURE']`

**Why:** Agentic wins by running 11 ehr.get_*/run_sql_query calls to gather labs and vitals beyond what the one-shot `<ehr_context>` snapshot (latest-80 rows) contains. One-shot guessed `['FUNGAL CULTURE']` from the truncated timeline.

---
### Agentic prompt (3215 chars)

```
<task_instruction>
Please give the next Microbiology Test Events suggestion for the patiens.

Analyze the patient's EHR records up to the current time to make your prediction.
Do not assume any unseen future events beyond the current time.
When you need medical knowledge or clinical information, use the `browser.search` tool to find authoritative medical information from reliable sources.
Submit your final answer through `ehr.finish`. Your answer must be chosen only from the candidate list below.
</task_instruction>

<patient_info>
Current Time: 2167-03-15 12:20:48
Patient Subject ID: 12138659
</patient_info>

<candidate_answers>
["VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS", "R/O Beta Strep Group A", "STOOL SMEAR FOR POLYMORPHONUCLEAR LEUKOCYTES", "BARTONELLA BLOOD CULTURE", "TREPONEMAL ANTIBODY TEST", "GENITAL CULTURE FOR TOXIC SHOCK", "TISSUE CULTURE-AMNIOTIC FLUID", "TISSUE CULTURE-FLUID", "M.FURFUR CULTURE", "SWAB- R/O YEAST", "Reflex HCV Qual PCR", "Blood Culture, Post Mortem", "CVS NEEDLE ASPIRATION EVALUATION", "RUBELLA IgG SEROLOGY", "Respiratory Viral Antigen Screen", "FLUID CULTURE", "Staph aureus Screen", "GRAM STAIN- R/O THRUSH", "EPSTEIN-BARR VIRUS EBNA IgG AB", "Enterovirus Culture", "Staph aureus Preop PCR", "CHROMOSOME ANALYSIS-NEOPLASTIC BLOOD", "C. difficile Toxin antigen assay", "SMEAR FOR BACTERIAL VAGINOSIS", "POSTMORTEM CULTURE", "HCV GENOTYPE", "QUANTITATIVE CRYPTOCOCCAL ANTIGEN", "HELICOBACTER PYLORI ANTIBODY TEST", "Tissue culture for additional cells", "HBV Viral Load", "Blood Culture, Routine", "MICROSPORIDIA STAIN", "CHROMOSOME ANALYSIS-FLUID", "RUBEOLA ANTIBODY, IgG", "Malaria Antigen Test", "Immunofluorescent test for Pneumocystis jirovecii (carinii)", "CRYPTOCOCCAL ANTIGEN", "DIRECT INFLUENZA B ANTIGEN TEST", "POST-MORTEM VIRAL CULTURE", "ACID FAST CULTURE", "BLOOD/AFB CULTURE", "ISOLATE FOR MIC", "MUMPS IgG ANTIBODY", "Tissue Culture - Neoplastic Blood", "Direct Antigen Test for Herpes Simplex Virus Types 1 & 2", "CHLAMYDIA CULTURE", "NOCARDIA CULTURE", "EPSTEIN-BARR VIRUS VCA-IgG AB", "FECAL CULTURE", "VARICELLA-ZOSTER IgG SEROLOGY", "CMV IgM ANTIBODY", "MODIFIED ACID-FAST STAIN FOR NOCARDIA", "HCV VIRAL LOAD", "REFLEX URINE CULTURE", "C. difficile PCR", "TISSUE CULTURE-LYMPHOCYTE", "ASO Screen", "Swab - R/O Yeast - IC", "CHROMOSOME ANALYSIS-CVS", "Tissue Culture-Bone Marrow", "Respiratory Viral Culture", "NEISSERIA GONORRHOEAE (GC), NUCLEIC ACID PROBE, WITH AMPLIFICATION", "DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS", "ANAEROBIC CULTURE", "FECAL CULTURE - R/O VIBRIO", "Respiratory Virus Identification", "Carbapenemase Resistant Enterobacteriaceae Screen", "RAPID PLASMA REAGIN TEST", "Cipro Resistant Screen", "FISH ANALYSIS, 10-30 CELLS", "CMV IgG ANTIBODY", "M. furfur Blood Culture", "CLOSTRIDIUM DIFFICILE TOXIN A & B TEST", "VIRAL CULTURE", "MOLECULAR CYTOGENETICS - DNA PROBE", "Fluid Culture in Bottles", "Anaerobic culture, Prosthetic Joint Fluid", "DIRECT RSV ANTIGEN TEST", "FUNGAL CULTURE", "VARICELLA-ZOSTER CULTURE", "INTERPHASE FISH ANALYSIS, 100-300 CELLS", "VIRAL CULTURE: R/O CYTOMEGALOVIRUS", "IMMUNOFLUORESCENT TEST FOR PNEUMOCYSTIS CARINII", "MRSA SCREEN", "MOLECULAR CYTOGENETICS-DNA Probe"]
</candidate_answers>
```

### Agentic tool-call sequence (18 calls)

ehr.load_ehr, ehr.get_table_names, ehr.get_column_names, ehr.get_column_names, ehr.get_latest_records, ehr.get_latest_records, ehr.think, ehr.run_sql_query, ehr.think, ehr.get_records_by_time, ehr.get_records_by_time, ehr.think, ehr.run_sql_query, ehr.run_sql_query, ehr.think, ehr.get_records_by_time, ehr.think, ehr.finish

### Agentic final assistant reasoning

> _(none)_

---
### One-shot prompt (36266 chars)

```
<task_instruction>
Given the sequence of events that have occurred in a hospital, please give the next Microbiology Test Events suggestion for the patiens.
All patient events needed for this task are already included below.
The current time is 2167-03-15 12:20:48, which is exactly one second after the latest observed event at 2167-03-15 12:20:47.
Use only the provided patient timeline.
Do not assume any unseen future events beyond the current time.
No EHR database lookup is needed for this record because the full timeline is embedded in the prompt.
Return only the final answer text. If multiple answers are needed, put one answer per line with no bullets or numbering. If candidate answers are provided, choose only from that candidate list.
</task_instruction>

<patient_info>
Current Time: 2167-03-15 12:20:48
</patient_info>

<patient_timeline>
## Patient Demographics [None]
- Anchor_Age: 48
- Gender: M

## Discharge [2167-02-23 00:00:00]
- Note_Type: DS
- Text:  
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
new clival mass in setting of relapsing mutliple myeloma 
admitted to expedite workup and treatment 
 
Major Surgical or Invasive Procedure:
chemotherapy
 
History of Present Illness:
___ man with multiple myeloma in relapse after 
autologous stem cell transplant in ___ Day 141. He is 
admitted for day 9 of Velcade, Cytoxan, and dexamethasone (was 
supposed to also get revelmed but didn't arrive until today so 
will get that here). Approximately 2 wks ago (1 day before 
getting chemo) pt had a small area of decreased sensation on his 
face in the V3 distribution. MRI was performed which showed a 
new clival mass. Current admission plan is to start radiation, 
obtain LP, and have neuro-onc evaluate the pt (specificly Dr. 
___. He has taken dexamethasone 20 mg/day on ___, 
___, and ___ and will likely continue 
this while inpt. He had been holding his PCP prophylaxis but 
should be restarted on Mepron. Also will be getting radiation 
treatment and velcade.  
.  
With respect to mass and decreased senation, pt stated it was 
more a lake of feeling than a numbness. This improved almost 
immediately ___ days of chemo and steriods. Area was the L 
lower lip and chin area, a small area of roughly a finger width. 
W/chemo and decadrone pulse, pt gradually felt tingling and 
return of sensation to the area although still feels there is 
residual sensation deficit. On ROS, pt is otherwise completely 
neurologically intact, no incontinence, pain, double vision, 
other loss of sensation or changes in balance. ROS was negative 
for other symptoms.  
.  
INTERVAL HISTORY since last admission: Pt noted numbness on the 
left side of his chin which he thought was getting better since 
when he first noticed it on ___ but continues to persist. 
MR on ___ night showed a new clival mass (final read 
pending). He took dexamethasone 20 mg/day since ___. He has 
no other complaints and specifically denies fevers, chills, 
congestion, cough, shortness  
of breath, chest pain, nausea, headache, vomiting, diarrhea,  
rash, bleeding, or bruising.  

 
Past Medical History:
ONCOLOGIC HISTORY From ___: Mr. ___ is a ___ man with 
multiple myeloma. His primary oncologist is Dr. ___. 
He has  
previously been treated with Revlimid, Velcade, and 
dexamethasone, followed by Revlimid, Velcade, dexamethasone, and 
Cytoxan- with improved response noted after the addition of 
Cytoxan. He received a single dose of Cytoxan at 1500 mg/m2, due 
to persistent marrow involvement (~30% by ___). This was 
followed by a single cycle of Cytoxan, Revlimid, Velcade, and 
dexamethasone. Bone marrow biopsy in ___ shows plasma cells 
at about 10% of the aspirate and about 30% by CD138 staining. 
Prior to auto-SCT, there is continued elevation in serum free 
kappa and free kappa lambda ratio. Mr. ___ also has some  
persistent renal insufficiency with a creatinine between 1.5 and 
1.7. As he appeared to have reached a response plateau, the 
decision was made to proceed with autologous stem cell 
transplant. He received a pre-transplant vaccine (protocol 
___ on ___. He was admitted on ___ for high dose 
Cytoxan and subsequently collected 4.85 million stem cells. He 
was admitted on ___ for autologous stem cell transplant and 
had his stem cells reinfused on ___.  
.  
He received 3 post transplant vaccines per protocol ___ 
before  
being noted for being noted for disease progression with a 
rising  
serum free kappa, extensive bone marrow involvement and elevated 
 
creatinine. He was started on therapy with Cytoxan, Velcade, and 
 
dexamethasone with a plan to add Revlimid when this medication 
is  
received from the specialty pharmacy.  
.  
Pt had a brief admission in ___ for expisode of 
diarrhea. See OMR for complete details.  
.  
.  
Past Medical History:  
Multiple myeloma:  
-S/p Auto-transplant on ___.  
-Currently on protocol ___, tumor fusion vaccine in 
conjunction with autologous stem cell transplant.  
- Has completed treatment with RVD initially, followed by 3  
cycles of CRVD, with the last dose of RVD admninistered on  
___ and the last dose of cyclophosphamide on ___  
- He also received radiation treatment to his right hip due to  
___ disease in ___ with good effects.  
.  
Other PMH:  
History of CHF with decline in EF, ejection fraction now >55%  
(by TTE ___.  
Renal insufficiency from Mulitple Myeloma (baseline Cr1.6-1.7)  
Hypogammaglobulinemia- last dose of IVIG given ___.  
SCC on abdomen.  
.  

 
Social History:
___
Family History:
CAD: Mother  
Kidney ___: Father s/p transplant in setting of infx w/ BPH.  

 
Physical Exam:
Vitals: T: 98.8 BP: 124/78 P: 80 R: 18 O2: 98% RA  
wgt; 155.5lb  
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, no ulcers or 
lesions.  
Neck: No lymphadenopthy appreciated  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly.  
GU: no foley  
Ext: warm, well perfused, no clubbing, cyanosis or edema  
Neuro: CNII-XII, gait entirely intact, coordination intact, only 
deficit observed was decrease in sensation in the low left side 
of lip and chin area (this is improved per pt from when first 
arose) 

VS: Tm 99.5 Tc 98.6 BP: 120/76 (118-130/76-80) HR: 90 (80-90) 
RR: 18 O2 Sat: 100 wgt:  
shift I=300/O= BR  
24hr I= /O=  
GEN: [x]NAD []Cacjectic  
SKIN: [x]WNL  
HEENT: [x]Anicteric [x]MMM [x]OP Clear [x]No LAD  
CV: [x]RRR [x]NML S1 S2 [x]no g/m/r [x]no JVD  
RESP: [x]CTAB [x]no wheezes/rhonchi/rales  
ABD: [x]S/NT/ND [x]+BS [x]No HSM  
EXT: [x]No CCE [x] +2 DP B/L  
NEURO: [x]A&Ox3 [x]CN2-12 intact [x] motor [x] sensory [x]coord 
[x]language normal  

 
Pertinent Results:
___ 06:25AM BLOOD WBC-5.4 RBC-3.55* Hgb-11.2* Hct-32.0* 
MCV-90 MCH-31.6 MCHC-35.1* RDW-13.4 Plt Ct-37*
___ 09:32AM BLOOD WBC-4.8 RBC-3.72* Hgb-12.1* Hct-33.9* 
MCV-91 MCH-32.5* MCHC-35.6* RDW-12.7 Plt Ct-46*
___ 06:25AM BLOOD Neuts-74* Bands-0 Lymphs-15* Monos-6 
Eos-0 Baso-0 Atyps-5* ___ Myelos-0
___ 09:32AM BLOOD Neuts-84* Bands-1 Lymphs-12* Monos-1* 
Eos-0 Baso-0 Atyps-2* ___ Myelos-0
___ 10:19AM BLOOD Plt Ct-73*#
___ 06:25AM BLOOD Plt Smr-VERY LOW Plt Ct-37*
___ 06:25AM BLOOD ___ PTT-21.7* ___
___ 09:32AM BLOOD Plt Smr-VERY LOW Plt Ct-46*
___ 06:25AM BLOOD ___ ___
___ 06:25AM BLOOD Glucose-127* UreaN-30* Creat-1.6* Na-138 
K-4.5 Cl-107 HCO3-18* AnGap-18
___ 09:32AM BLOOD UreaN-34* Creat-2.0* Na-138 K-4.1 Cl-104 
HCO3-20* AnGap-18
___ 06:25AM BLOOD ALT-19 AST-12 LD(LDH)-331* AlkPhos-94 
TotBili-0.2
___ 09:32AM BLOOD ALT-20 AST-16 LD(LDH)-388* AlkPhos-99 
TotBili-0.2
___ 06:25AM BLOOD Calcium-10.3 Phos-3.8 Mg-2.2
___ 09:32AM BLOOD Albumin-4.4 Calcium-10.0 Phos-3.9 Mg-2.___ man with multiple myeloma in relapse after 
autologous stem cell transplant in ___ Day 141. He is here 
today, day 9 of Velcade, Cytoxan, and dexamethasone (was 
supposed to also get revelmed but didn't arrive until today) 
with a small area of decreased sensation on his face in the V3 
distribution. MRI was performe which showed a new clival mass.  
.  
# Multiple Myeloma: Pt was scheduled to get revelmed but this 
did not arrive until day of admission. blood counts were 
monitored and readdress bone marrow biopsy as appopriate. 
Neuro-onc (Dr. ___ was consulted given new clival mass and 
decreased senation on his face. Improved w/steroids and chemo.   

.  
# Clival mass: Likely related to multiple myeloma. Workup 
initiated and chemo and steroids given. Neuro onc consulted as 
above. Outpt follow-up planned. 
.  
# Chronic Kidney Disease: Secondary to multiple myeloma with 
baseline creatinine 1.6 t 1.7. Presented with creatinine of 2.0 
today. Continued to monitor creatinine.  

 
Medications on Admission:
ACYCLOVIR - 400 mg Tablet - 1 Tablet(s) by mouth twice a day  
ATOVAQUONE [MEPRON] - (Dose adjustment - no new Rx) - 750 mg/5 
mL Suspension - 1500 mg(s) by mouth daily (10 mL)  
DEXAMETHASONE - 4 mg Tablet - 5 Tablet(s) by mouth once a day 
for 4 days after chemotherapy  
LENALIDOMIDE [REVLIMID] - (Prescribed by Other Provider) - 10 mg 
Capsule - 1 Capsule(s) by mouth once a day ___ ___ *pt has 
not started this medication*  
LORAZEPAM - 0.5 mg Tablet - 1 to 2 Tablet(s) by mouth every six 
(6) hours as needed for nausea  
LORAZEPAM [ATIVAN] - 0.5 mg Tablet - ___ Tablet(s) by mouth 
every ___ hours as needed for nausea/insomnia/anxiety  
ONDANSETRON - 4 mg Tablet, Rapid Dissolve - 1 Tablet(s) by mouth 
every eight (8) hours as needed for nausea  
PROCHLORPERAZINE MALEATE - 10 mg Tablet - 1 Tablet(s) by mouth 
every eight (8) hours as needed for nausea  

 
Discharge Medications:
1. atovaquone 750 mg/5 mL Suspension Sig: Two (2)  PO DAILY 
(Daily).  
2. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours).
Disp:*90 Tablet(s)* Refills:*2*
3. lorazepam 0.5 mg Tablet Sig: ___ Tablets PO every six (6) 
hours as needed for nausea/insomnia/anxiety.  
4. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, 
Rapid Dissolve PO every eight (8) hours as needed for nausea.  
5. prochlorperazine maleate 10 mg Tablet Sig: One (1) Tablet PO 
every eight (8) hours as needed for nausea.  
6. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.
Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*2*
7. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO every six 
(6) hours for 14 days.
Disp:*56 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Multiple myeloma with evidence of skull changes on MRI
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
You were admitted to the hospital for additional chemosterapy 
and to have further workup and evaluation of the changes found 
on MRI in your skull (likely related to your multiple myeloma). 
You were seen by a neuro-oncologist and also say the radiation 
oncologist. You also received your chemo therapay medications 
(revelmed and velcade as well as decadron). You did well and 
were able to be discharged home while awaiting your next 
scheduled treatment session. 
.
The following changes were made you your medications:
- Please START taking omeprazole 40mg daily (this is to help 
protect your stomach especially while you are taking steroids)
- Please CHANGE your dose of Acyclovir 400 mg every 8 hours 
(three times a day)
- Please CONTINUE taking dexamethasone (decadron) 4 mg 6 hours
- Please continue to take all of your other home medications as 
prescribed.
Please be sure to take all medication as prescribed.
.
Please be sure to keep all follow-up appointments with your PCP, 
oncologist and other healthcare providers.
.
It was a pleasure taking care of you and we wish you a speedy 
recovery.

 
Followup Instructions:
___


## Admissions [2167-03-14 17:15:00]
- Admission_Type: DIRECT EMER.
- Admission_Location: CLINIC REFERRAL
- Admission_Info: None

## Radiology Examinations [2167-03-14 15:35:00]
- Note_Type: RR
- Exam_Name: ['CHEST (PA & LAT)']
- Text: CLINICAL HISTORY:  Cough.

COMPARISON:  CXR ___ and ___ CT ___.

FINDINGS:  The lungs are well expanded and clear without focal consolidation,
pleural effusion or pneumothorax.  The cardiac and mediastinal silhouettes and
hilar contours are normal.  Periosteal reaction at the lateral aspect of the
left sixth rib may be due to myeloma infiltration.

IMPRESSION:  No acute cardiopulmonary process.

Discussed with ___ by phone, 4:45 p.m., ___.


## Labotary Test Events [2167-03-14 15:55:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Anisocytosis | nan | nan | nan | nan | nan | NORMAL. |
| Atypical Lymphocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Bands | 0.0 | % | 0.0 | 5.0 | nan | nan |
| Basophilic Stippling | nan | nan | nan | nan | nan | OCCASIONAL. |
| Basophils | 0.0 | % | 0.0 | 2.0 | nan | nan |
| Eosinophils | 2.0 | % | 0.0 | 4.0 | nan | nan |
| Hematocrit | 28.2 | % | 40.0 | 52.0 | abnormal | nan |
| Hemoglobin | 10.1 | g/dL | 14.0 | 18.0 | abnormal | nan |
| Hypochromia | nan | nan | nan | nan | nan | NORMAL. |
| Lymphocytes | 38.0 | % | 18.0 | 42.0 | nan | nan |
| Macrocytes | nan | nan | nan | nan | nan | NORMAL. |
| MCH | 32.8 | pg | 27.0 | 32.0 | abnormal | nan |
| MCHC | 35.9 | % | 31.0 | 35.0 | abnormal | nan |
| MCV | 92.0 | fL | 82.0 | 98.0 | nan | nan |
| Metamyelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Microcytes | nan | nan | nan | nan | nan | NORMAL. |
| Monocytes | 9.0 | % | 2.0 | 11.0 | nan | nan |
| Myelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Neutrophils | 31.0 | % | 50.0 | 70.0 | abnormal | nan |
| Plasma Cells | 19.0 | % | 0.0 | 0.0 | abnormal | ___ |
| Platelet Count | 40.0 | K/uL | 150.0 | 440.0 | abnormal | nan |
| Platelet Smear | nan | nan | nan | nan | nan | VERY LOW. |
| Poikilocytosis | nan | nan | nan | nan | nan | NORMAL. |
| Polychromasia | nan | nan | nan | nan | nan | OCCASIONAL. |
| Promyelocytes | 1.0 | % | 0.0 | 0.0 | abnormal | nan |
| RDW | 14.7 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 3.09 | m/uL | 4.6 | 6.2 | abnormal | nan |
| Spherocytes | nan | nan | nan | nan | nan | OCCASIONAL. |
| White Blood Cells | 4.0 | K/uL | 4.0 | 11.0 | nan | nan |
| Alanine Aminotransferase (ALT) | 53.0 | IU/L | 0.0 | 40.0 | abnormal | nan |
| Alkaline Phosphatase | 102.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Anion Gap | 21.0 | mEq/L | 8.0 | 20.0 | abnormal | nan |
| Asparate Aminotransferase (AST) | 26.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bicarbonate | 18.0 | mEq/L | 22.0 | 32.0 | abnormal | nan |
| Bilirubin, Total | 0.3 | mg/dL | 0.0 | 1.5 | nan | nan |
| Calcium, Total | 9.8 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 99.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 2.2 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Lactate Dehydrogenase (LD) | 402.0 | IU/L | 94.0 | 250.0 | abnormal | nan |
| Magnesium | 1.7 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 3.1 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 4.0 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 134.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 39.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |
| INR(PT) | 1.2 | nan | 0.9 | 1.1 | abnormal | nan |
| PT | 13.9 | sec | 10.4 | 13.4 | abnormal | nan |

## Services [2167-03-14 17:16:25]
- Curr_Service: OMED

## Transfers [2167-03-14 17:16:25]
- Eventtype: admit
- Careunit: Hematology/Oncology

## Provider Order Entry [2167-03-14 17:52:37]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Medications | nan |
| ADT orders | Admit |
| IV therapy | IV access |
| Medications | nan |
| General Care | Vitals/Monitoring |
| General Care | Activity |
| Nutrition | Diet Order |
| Medications | nan |
| Lab | nan |
| IV therapy | IV access request |

## Pharmacy [2167-03-14 18:07:11]
| Medication | Proc_Type | Status |
| ------ | ------ | ------ |
| Sodium Chloride 0.9%  Flush | Unit Dose | Discontinued via patient discharge |
| Omeprazole | Unit Dose | Discontinued via patient discharge |

## Provider Order Entry [2167-03-14 18:27:25]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Radiology | CT Scan |
| Cardiology | Echo |
| Lab | nan |
| Lab | nan |
| Medications | nan |

## Microbiology Test Events [2167-03-14 18:35:00]
- Test_Name: Blood Culture, Routine
- Dilution_Text: nan
- Interpretation: nan
- Comments: NO GROWTH.  
- Ab_Name: nan

## Provider Order Entry [2167-03-14 18:40:35]
- Order_Type: Lab
- Order_Subtype: nan

## Pharmacy [2167-03-14 18:58:07]
- Medication: CefePIME
- Proc_Type: IV Piggyback
- Status: Discontinued

## Prescriptions [2167-03-14 19:00:00]
| Drug | Atc Type | Prod_Strength | Dose_Val_Rx | Dose_Unit_Rx |
| ------ | ------ | ------ | ------ | ------ |
| 0.9% Sodium Chloride (Mini Bag Plus) | sodium chloride | 100mL Bag | 100 | mL |
| CefePIME | cefepime | 2g Vial | 2 | g |
| Sodium Chloride 0.9%  Flush | None | Syringe | 3 | mL |

## Provider Order Entry [2167-03-14 19:15:54]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Lab | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| Medications | nan |
| General Care | Other |
| General Care | Other |
| IV therapy | IV fluids |
| General Care | Other |
| Medications | nan |
| Medications | nan |

## Pharmacy [2167-03-14 20:04:12]
| Medication | Proc_Type | Status |
| ------ | ------ | ------ |
| Ondansetron | IV Piggyback | Expired |
| Lorazepam | Unit Dose | Discontinued |
| Lorazepam | Unit Dose | Discontinued |
| Lorazepam | Unit Dose | Discontinued |
| nan | IV Large Volume | Discontinued |
| Dexamethasone | IV Piggyback | Inactive (Due to a change order) |
| Dexamethasone | IV Piggyback | Inactive (Due to a change order) |
| Cyclophosphamide | IV Piggyback | Expired |
| Mesna | IV Large Volume | Expired |
| Lorazepam | Unit Dose | Expired |
| Acetaminophen | Unit Dose | Discontinued via patient discharge |
| VinCRIStine (Oncovin) | IV Piggyback | Inactive (Due to a change order) |
| DOXOrubicin | IV Piggyback | Inactive (Due to a change order) |

## Provider Order Entry [2167-03-14 20:52:39]
| Order_Type | Order_Subtype |
| ------ | ------ |
| IV therapy | IV access |
| Medications | nan |
| Radiology | General Xray |

## Radiology Examinations [2167-03-14 20:55:00]
- Note_Type: RR
- Exam_Name: ['CHEST PORT. LINE PLACEMENT']
- Text: HISTORY:  PICC placement.

FINDINGS:  In comparison with the earlier study of this date, there has been
placement of a left subclavian PICC line that extends to the mid-to-lower
portion of the SVC.  This information was discussed with the IV nurse by the
resident on call.

The lungs remain clear.


## Prescriptions [2167-03-14 21:00:00]
| Drug | Atc Type | Prod_Strength | Dose_Val_Rx | Dose_Unit_Rx |
| ------ | ------ | ------ | ------ | ------ |
| Lorazepam | nan | 1mg Tablet | 1 | mg |
| Lorazepam | lorazepam | 2mg/mL Syringe | 0.5-2 | mg |
| Acetaminophen | nan | 325mg Tablet | 325-650 | mg |
| Lorazepam | nan | 0.5mg Tablet | 0.5-2 | mg |
| 5% Dextrose | glucose | 250mL Bag | 250 | mL |
| Cyclophosphamide | cyclophosphamide | 1000mg Vial | 540 | mg |
| 0.9% Sodium Chloride | sodium chloride | 1000mL Bag | 1000 | mL |
| Mesna | mesna | 1g Vial | 1090 | mg |
| 5% Dextrose | glucose | 50mL Bag | 50 | mL |
| Dexamethasone Sod Phosphate | dexamethasone | 10mg/mL 10mL Vial | 40 | mg |
| 5% Dextrose | glucose | 1000mL Bag | 1000 | mL |
| Sodium Bicarbonate | sodium bicarbonate | 50mEq Vial | 150 | mEq |
| Lorazepam | nan | 1mg Tablet | 0.5-2 | mg |
| 5% Dextrose | glucose | 50mL Bag | 50 | mL |
| Ondansetron | ondansetron | 2mg/mL-2mL | 24 | mg |

## Pharmacy [2167-03-14 21:00:10]
- Medication: Heparin Flush (10 units/ml)
- Proc_Type: Unit Dose
- Status: Discontinued

## Labotary Test Events [2167-03-14 21:25:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Bilirubin | nan | mg/dL | nan | nan | nan | NEG. |
| Blood | nan | nan | nan | nan | nan | TR. |
| Glucose | nan | mg/dL | nan | nan | nan | NEG. |
| Ketone | nan | mg/dL | nan | nan | nan | NEG. |
| Leukocytes | nan | nan | nan | nan | nan | NEG. |
| Nitrite | nan | nan | nan | nan | nan | NEG. |
| pH | 5.5 | units | 5.0 | 8.0 | nan | nan |
| Protein | nan | mg/dL | nan | nan | nan | TR. |
| Specific Gravity | 1.008 |   | 1.001 | 1.035 | nan | nan |
| Urine Appearance | nan | nan | nan | nan | nan | Clear. |
| Urine Color | nan | nan | nan | nan | nan | Straw. |
| Urobilinogen | nan | mg/dL | 0.2 | 1.0 | nan | NEG. |

## Prescriptions [2167-03-14 22:00:00]
- Drug: Heparin Flush (10 units/ml)
- Atc Type: heparin
- Prod_Strength: 10 Units/mL - 5 mL Syringe
- Dose_Val_Rx: 2
- Dose_Unit_Rx: mL

## Provider Order Entry [2167-03-14 23:27:39]
- Order_Type: General Care
- Order_Subtype: Other

## Labotary Test Events [2167-03-15 00:00:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Anisocytosis | nan | nan | nan | nan | nan | OCCASIONAL. |
| Atypical Lymphocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Bands | 4.0 | % | 0.0 | 5.0 | nan | nan |
| Basophils | 0.0 | % | 0.0 | 2.0 | nan | nan |
| Eosinophils | 2.0 | % | 0.0 | 4.0 | nan | nan |
| Granulocyte Count | 860.0 | #/uL | 2200.0 | 8250.0 | abnormal | nan |
| Hematocrit | 22.4 | % | 40.0 | 52.0 | abnormal | nan |
| Hemoglobin | 7.9 | g/dL | 14.0 | 18.0 | abnormal | nan |
| Hypochromia | nan | nan | nan | nan | nan | OCCASIONAL. |
| Lymphocytes | 30.0 | % | 18.0 | 42.0 | nan | nan |
| Macrocytes | nan | nan | nan | nan | nan | OCCASIONAL. |
| MCH | 32.0 | pg | 27.0 | 32.0 | nan | nan |
| MCHC | 35.2 | % | 31.0 | 35.0 | abnormal | nan |
| MCV | 91.0 | fL | 82.0 | 98.0 | nan | nan |
| Metamyelocytes | 4.0 | % | 0.0 | 0.0 | abnormal | nan |
| Microcytes | nan | nan | nan | nan | nan | NORMAL. |
| Monocytes | 6.0 | % | 2.0 | 11.0 | nan | nan |
| Myelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Neutrophils | 42.0 | % | 50.0 | 70.0 | abnormal | TOXIC GRANULATIONS. |
| Plasma Cells | 12.0 | % | 0.0 | 0.0 | abnormal | nan |
| Platelet Count | 29.0 | K/uL | 150.0 | 440.0 | abnormal | nan |
| Poikilocytosis | nan | nan | nan | nan | nan | NORMAL. |
| Polychromasia | nan | nan | nan | nan | nan | NORMAL. |
| RDW | 14.6 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 2.47 | m/uL | 4.6 | 6.2 | abnormal | nan |
| White Blood Cells | 1.9 | K/uL | 4.0 | 11.0 | abnormal | nan |
| INR(PT) | 1.3 | nan | 0.9 | 1.1 | abnormal | nan |
| PT | 14.5 | sec | 10.4 | 13.4 | abnormal | nan |
| PTT | 24.2 | sec | 22.0 | 35.0 | nan | nan |
| Alanine Aminotransferase (ALT) | 46.0 | IU/L | 0.0 | 40.0 | abnormal | nan |
| Albumin | 3.2 | g/dL | 3.5 | 5.2 | abnormal | nan |
| Alkaline Phosphatase | 88.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Anion Gap | 15.0 | mEq/L | 8.0 | 20.0 | nan | nan |
| Asparate Aminotransferase (AST) | 23.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bicarbonate | 20.0 | mEq/L | 22.0 | 32.0 | abnormal | nan |
| Bilirubin, Total | 0.2 | mg/dL | 0.0 | 1.5 | nan | nan |
| Calcium, Total | 8.6 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 104.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 2.3 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Globulin | 2.1 | g/dL | 2.0 | 4.0 | nan | nan |
| Glucose | 137.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |
| Immunofixation | nan | nan | nan | nan | nan | ___ |
| Immunoglobulin A | 19.0 | mg/dL | 70.0 | 400.0 | abnormal | nan |
| Immunoglobulin G | 294.0 | mg/dL | 700.0 | 1600.0 | abnormal | nan |
| Immunoglobulin M | 10.0 | mg/dL | 40.0 | 230.0 | abnormal | nan |
| Lactate Dehydrogenase (LD) | 315.0 | IU/L | 94.0 | 250.0 | abnormal | nan |
| Magnesium | 1.6 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 4.5 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 3.6 | mEq/L | 3.3 | 5.1 | nan | nan |
| Protein Electrophoresis | nan | nan | nan | nan | nan | ___ |
| Protein, Total | 5.3 | g/dL | 6.4 | 8.3 | abnormal | nan |
| Sodium | 135.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 39.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |

## Microbiology Test Events [2167-03-15 00:00:00]
- Test_Name: Blood Culture, Routine
- Dilution_Text: nan
- Interpretation: nan
- Comments: NO GROWTH.  
- Ab_Name: nan

## Procedures on International Classification of Diseases [2167-03-15 00:00:00]
- Procedures: Injection or infusion of cancer chemotherapeutic substance
- Ccs Type: Cancer chemotherapy

## Labotary Test Events [2167-03-15 01:39:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Hematocrit | 22.4 | % | 40.0 | 52.0 | abnormal | nan |
| Hemoglobin | 8.0 | g/dL | 14.0 | 18.0 | abnormal | nan |
| MCH | 32.1 | pg | 27.0 | 32.0 | abnormal | nan |
| MCHC | 35.7 | % | 31.0 | 35.0 | abnormal | nan |
| MCV | 90.0 | fL | 82.0 | 98.0 | nan | nan |
| Platelet Count | 21.0 | K/uL | 150.0 | 440.0 | abnormal | nan |
| RDW | 15.8 | % | 10.5 | 15.5 | abnormal | nan |
| Red Blood Cells | 2.5 | m/uL | 4.6 | 6.2 | abnormal | nan |
| White Blood Cells | 1.8 | K/uL | 4.0 | 11.0 | abnormal | nan |

## Provider Order Entry [2167-03-15 01:45:30]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Lab | nan |
| Blood Bank | Red Cell Product Order |
| Medications | nan |
| Medications | nan |
| Medications | nan |

## Pharmacy [2167-03-15 07:24:47]
| Medication | Proc_Type | Status |
| ------ | ------ | ------ |
| Potassium Chloride Replacement (Oncology) | IV Piggyback | Discontinued |
| Potassium Chloride Replacement (Oncology) | IV Piggyback | Discontinued |
| Magnesium Sulfate Replacement (Oncology) | IV Piggyback | Discontinued via patient discharge |
| Magnesium Sulfate Replacement (Oncology) | IV Piggyback | Discontinued via patient discharge |
| Magnesium Sulfate Replacement (Oncology) | IV Piggyback | Discontinued via patient discharge |
| Potassium Phosphate Replacement (Oncology) | IV Piggyback | Discontinued via patient discharge |

## Prescriptions [2167-03-15 08:00:00]
| Drug | Atc Type | Prod_Strength | Dose_Val_Rx | Dose_Unit_Rx |
| ------ | ------ | ------ | ------ | ------ |
| Bag | None | 50 mL Bag | 100 | mL |
| Magnesium Sulfate | magnesium sulfate | 2 g / 50 mL Premix Bag | 4 | gm |
| Bag | None | 50 mL Bag | 50 | mL |
| Magnesium Sulfate | magnesium sulfate | 2 g / 50 mL Premix Bag | 2 | gm |
| Bag | None | 50 mL Bag | 100 | mL |
| Magnesium Sulfate | magnesium sulfate | 2 g / 50 mL Premix Bag | 2-4 | gm |
| Sterile Water | None | 50 mL Bag | 50 | mL |
| Potassium Chloride | potassium chloride | 20mEq/50mL Premix | 40 | mEq |
| Sterile Water | None | 50 mL Bag | 50 | mL |
| Potassium Chloride | potassium chloride | 20mEq/50mL Premix | 60 | mEq |
| 0.9% Sodium Chloride | sodium chloride | 250mL Bag | 250 | mL |
| Potassium Phosphate | electrolytes | 3mM/mL-15mL | 15 | mmol |

## Radiology Examinations [2167-03-15 08:03:00]
- Note_Type: RR
- Exam_Name: ['CT CHEST W/O CONTRAST']
- Text: CLINICAL HISTORY:  Refractory multiple myeloma status post autologous
transplant, day +162, presenting with cough and dyspnea on exertion.

COMPARISON:  CT ___, CXR ___.

TECHNIQUE:  Multidetector CT acquisition of the chest was performed without
intravenous or oral contrast.  Images are presented for display in the axial
plane at 1.25-mm and 5-mm collimation.  Coronal and sagittal reformats were
also submitted for review.

CT OF THE CHEST WITHOUT INTRAVENOUS CONTRAST:  The thoracic aorta is normal in
caliber without evidence of acute intramural hematoma.  No pathologically
enlarged mediastinal, axillary or hilar lymph nodes are present.  Myocardium
is denser than blood in the intracardiac chambers, consistent with anemia. 
The pericardium and great vessels are within normal limits.  No pericardial or
pleural effusion is demonstrated.  The thyroid is unremarkable without
nodules.

LUNG WINDOWS:  In the posterior segment of the right upper lobe along the
fissure are clustered predominantly ground-glass nodular opacities.  Similar
opacities are seen in the medial segment of the right middle lobe and medial
basal segment of the right lower lobe.  In the right lower lobe superior
segment, similar opacities are ground-glass and nodular with clear
peribronchial distribution and ___ appearance.  A small amount of left
basilar atelectasis is seen.  Airways are patent to the level of the
subsegmental bronchi bilaterally. A right central catheter extends to the
right atrium just beyond the superior cavoatrial junction.


The study is not tailored for subdiaphragmatic evaluation.  Within this
limitation, the upper abdominal organs are unremarkable.

BONE WINDOWS: Extensive myelomatous involvement of the chest cage with marked
involvement of T5, T6 and T11 as well as multiple ribs is again seen,
unchanged since ___.  The sternum is diffusely lytic.  There is no soft
tissue mass associated with any chest cage involvement. The visualized outline
of the thecal sac appears unremarkable, although CT cannot provide intrathecal
detail compared to MRI.

IMPRESSION: 
1. Multiple ground-glass nodular opacities in the right upper, middle and
lower lobes are likely due to airborne infection such as bacterial, mycoplasma
or viral pneumonia.  The radiologic appearance is unlikely to represent
aspergillosis, but in an immunocompromised individual, aspergillosis cannot be
excluded.  Given that the patient is greater than three months from
transplant, cryptogenic organizing pneumonia is also a consideration.
2. Diffuse myelomatous involvement of the thoracic cage, unchanged from
___.
3. Myocardium is denser than blood within the intracardiac chambers,
consistent with anemia.

Discussed with Dr. ___ by phone at 2:30 p.m., ___.


## Provider Order Entry [2167-03-15 11:50:46]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Lab | nan |
| Lab | nan |

## Labotary Test Events [2167-03-15 12:14:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Alanine Aminotransferase (ALT) | 45.0 | IU/L | 0.0 | 40.0 | abnormal | nan |
| Albumin | 3.2 | g/dL | 3.5 | 5.2 | abnormal | nan |
| Alkaline Phosphatase | 86.0 | IU/L | 40.0 | 130.0 | nan | nan |
| Anion Gap | 18.0 | mEq/L | 8.0 | 20.0 | nan | nan |
| Asparate Aminotransferase (AST) | 17.0 | IU/L | 0.0 | 40.0 | nan | nan |
| Bicarbonate | 23.0 | mEq/L | 22.0 | 32.0 | nan | nan |
| Bilirubin, Total | 0.3 | mg/dL | 0.0 | 1.5 | nan | nan |
| Calcium, Total | 8.9 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 102.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 1.8 | mg/dL | 0.5 | 1.2 | abnormal | nan |
| Glucose | 241.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |
| Lactate Dehydrogenase (LD) | 273.0 | IU/L | 94.0 | 250.0 | abnormal | nan |
| Magnesium | 2.0 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 3.0 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 3.2 | mEq/L | 3.3 | 5.1 | abnormal | nan |
| Sodium | 140.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 32.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |
| Anisocytosis | nan | nan | nan | nan | nan | NORMAL. |
| Atypical Lymphocytes | 7.0 | % | 0.0 | 0.0 | abnormal | nan |
| Bands | 0.0 | % | 0.0 | 5.0 | nan | nan |
| Basophils | 0.0 | % | 0.0 | 2.0 | nan | nan |
| Eosinophils | 0.0 | % | 0.0 | 4.0 | nan | nan |
| Hematocrit | 27.2 | % | 40.0 | 52.0 | abnormal | nan |
| Hemoglobin | 9.7 | g/dL | 14.0 | 18.0 | abnormal | nan |
| Hypochromia | nan | nan | nan | nan | nan | NORMAL. |
| Lymphocytes | 16.0 | % | 18.0 | 42.0 | abnormal | nan |
| Macrocytes | nan | nan | nan | nan | nan | NORMAL. |
| MCH | 32.2 | pg | 27.0 | 32.0 | abnormal | nan |
| MCHC | 35.7 | % | 31.0 | 35.0 | abnormal | nan |
| MCV | 90.0 | fL | 82.0 | 98.0 | nan | nan |
| Metamyelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Microcytes | nan | nan | nan | nan | nan | NORMAL. |
| Monocytes | 5.0 | % | 2.0 | 11.0 | nan | nan |
| Myelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Neutrophils | 72.0 | % | 50.0 | 70.0 | abnormal | nan |
| Ovalocytes | nan | nan | nan | nan | nan | OCCASIONAL. |
| Platelet Count | 21.0 | K/uL | 150.0 | 440.0 | abnormal | nan |
| Platelet Smear | nan | nan | nan | nan | nan | VERY LOW. |
| Poikilocytosis | nan | nan | nan | nan | nan | OCCASIONAL. |
| Polychromasia | nan | nan | nan | nan | nan | NORMAL. |
| RDW | 15.1 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 3.02 | m/uL | 4.6 | 6.2 | abnormal | nan |
| White Blood Cells | 2.4 | K/uL | 4.0 | 11.0 | abnormal | nan |

## Provider Order Entry [2167-03-15 12:20:47]
- Order_Type: Lab
- Order_Subtype: nan
</patient_timeline>

<candidate_answers>
["VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS", "R/O Beta Strep Group A", "STOOL SMEAR FOR POLYMORPHONUCLEAR LEUKOCYTES", "BARTONELLA BLOOD CULTURE", "TREPONEMAL ANTIBODY TEST", "GENITAL CULTURE FOR TOXIC SHOCK", "TISSUE CULTURE-AMNIOTIC FLUID", "TISSUE CULTURE-FLUID", "M.FURFUR CULTURE", "SWAB- R/O YEAST", "Reflex HCV Qual PCR", "Blood Culture, Post Mortem", "CVS NEEDLE ASPIRATION EVALUATION", "RUBELLA IgG SEROLOGY", "Respiratory Viral Antigen Screen", "FLUID CULTURE", "Staph aureus Screen", "GRAM STAIN- R/O THRUSH", "EPSTEIN-BARR VIRUS EBNA IgG AB", "Enterovirus Culture", "Staph aureus Preop PCR", "CHROMOSOME ANALYSIS-NEOPLASTIC BLOOD", "C. difficile Toxin antigen assay", "SMEAR FOR BACTERIAL VAGINOSIS", "POSTMORTEM CULTURE", "HCV GENOTYPE", "QUANTITATIVE CRYPTOCOCCAL ANTIGEN", "HELICOBACTER PYLORI ANTIBODY TEST", "Tissue culture for additional cells", "HBV Viral Load", "Blood Culture, Routine", "MICROSPORIDIA STAIN", "CHROMOSOME ANALYSIS-FLUID", "RUBEOLA ANTIBODY, IgG", "Malaria Antigen Test", "Immunofluorescent test for Pneumocystis jirovecii (carinii)", "CRYPTOCOCCAL ANTIGEN", "DIRECT INFLUENZA B ANTIGEN TEST", "POST-MORTEM VIRAL CULTURE", "ACID FAST CULTURE", "BLOOD/AFB CULTURE", "ISOLATE FOR MIC", "MUMPS IgG ANTIBODY", "Tissue Culture - Neoplastic Blood", "Direct Antigen Test for Herpes Simplex Virus Types 1 & 2", "CHLAMYDIA CULTURE", "NOCARDIA CULTURE", "EPSTEIN-BARR VIRUS VCA-IgG AB", "FECAL CULTURE", "VARICELLA-ZOSTER IgG SEROLOGY", "CMV IgM ANTIBODY", "MODIFIED ACID-FAST STAIN FOR NOCARDIA", "HCV VIRAL LOAD", "REFLEX URINE CULTURE", "C. difficile PCR", "TISSUE CULTURE-LYMPHOCYTE", "ASO Screen", "Swab - R/O Yeast - IC", "CHROMOSOME ANALYSIS-CVS", "Tissue Culture-Bone Marrow", "Respiratory Viral Culture", "NEISSERIA GONORRHOEAE (GC), NUCLEIC ACID PROBE, WITH AMPLIFICATION", "DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS", "ANAEROBIC CULTURE", "FECAL CULTURE - R/O VIBRIO", "Respiratory Virus Identification", "Carbapenemase Resistant Enterobacteriaceae Screen", "RAPID PLASMA REAGIN TEST", "Cipro Resistant Screen", "FISH ANALYSIS, 10-30 CELLS", "CMV IgG ANTIBODY", "M. furfur Blood Culture", "CLOSTRIDIUM DIFFICILE TOXIN A & B TEST", "VIRAL CULTURE", "MOLECULAR CYTOGENETICS - DNA PROBE", "Fluid Culture in Bottles", "Anaerobic culture, Prosthetic Joint Fluid", "DIRECT RSV ANTIGEN TEST", "FUNGAL CULTURE", "VARICELLA-ZOSTER CULTURE", "INTERPHASE FISH ANALYSIS, 100-300 CELLS", "VIRAL CULTURE: R/O CYTOMEGALOVIRUS", "IMMUNOFLUORESCENT TEST FOR PNEUMOCYSTIS CARINII", "MRSA SCREEN", "MOLECULAR CYTOGENETICS-DNA Probe"]
</candidate_answers>

---
After any reasoning, emit your final answer inside an <answer>...</answer> XML block as the very last thing you write. Put one answer per line inside the block, with no bullets, numbering, or markdown. If the task expects a single polar answer, put just that one line. If <candidate_answers> were provided, each line must match a candidate verbatim.
```

### One-shot final assistant reasoning

> Looking at this patient's timeline, I need to identify what microbiology test would logically come next.
> 
> Key clinical context:
> - 48-year-old male with relapsing multiple myeloma, post-autologous stem cell transplant (day +162)
> - Admitted with cough and dyspnea on exertion
> - Severely immunocompromised (WBC 2.4, platelets 21, neutropenic)
> - CT chest shows multiple ground-glass nodular opacities in right lung - reported as likely airborne infection (bacterial, mycoplasma, viral pneumonia), with aspergillosis not excluded in immunocompromised patient
> - Already on cefepime (febrile neutropenia cov…
